NHS hospitals to test AI tool that helps diagnose and treat prostate cancer
PositiveArtificial Intelligence

NHS hospitals are set to trial an innovative AI tool designed to enhance the diagnosis and treatment of prostate cancer. This three-year study, backed by Prostate Cancer UK and led by researchers from the University of Oxford, aims to improve patient outcomes by identifying men who are likely to benefit from specific drugs. The £1.9 million Vanguard Path study represents a significant step forward in utilizing technology to tackle one of the most common cancers in men, potentially transforming how prostate cancer is managed.
— Curated by the World Pulse Now AI Editorial System
